These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7736452)
1. Photodynamic therapy of photofrin II and excimer dye laser on experimental tumors. Tanaka M; Uchibayashi T; Obata T; Sasaki T Cancer Lett; 1995 Apr; 90(2):163-9. PubMed ID: 7736452 [TBL] [Abstract][Full Text] [Related]
2. The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro. Pope AJ; Masters JR; MacRobert AJ Urol Res; 1990; 18(4):267-70. PubMed ID: 2145683 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy in the management of bladder cancer. Nseyo UO J Clin Laser Med Surg; 1996 Oct; 14(5):271-80. PubMed ID: 9612193 [TBL] [Abstract][Full Text] [Related]
4. A comparison between argon-dye and excimer-dye laser for photodynamic effect in transplanted mouse tumor. Okunaka T; Kato H; Konaka C; Sakai H; Kawabe H; Aizawa K Jpn J Cancer Res; 1992 Feb; 83(2):226-31. PubMed ID: 1556004 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. Nseyo UO; DeHaven J; Dougherty TJ; Potter WR; Merrill DL; Lundahl SL; Lamm DL J Clin Laser Med Surg; 1998 Feb; 16(1):61-8. PubMed ID: 9728133 [TBL] [Abstract][Full Text] [Related]
6. Cooperative clinical trial of photodynamic therapy with photofrin II and excimer dye laser for early gastric cancer. Mimura S; Ito Y; Nagayo T; Ichii M; Kato H; Sakai H; Goto K; Noguchi Y; Tanimura H; Nagai Y; Suzuki S; Hiki Y; Hayata Y Lasers Surg Med; 1996; 19(2):168-72. PubMed ID: 8887919 [TBL] [Abstract][Full Text] [Related]
7. Photofrin II as an efficient radiosensitizing agent in an experimental tumor. Schaffer M; Schaffer PM; Corti L; Sotti G; Hofstetter A; Jori G; Dühmke E Onkologie; 2001 Oct; 24(5):482-5. PubMed ID: 11694776 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment. Kashtan H; Haddad R; Yossiphov Y; Bar-On S; Skornick Y Dis Colon Rectum; 1996 Apr; 39(4):379-83. PubMed ID: 8878495 [TBL] [Abstract][Full Text] [Related]
9. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy. Adams K; Rainbow AJ; Wilson BC; Singh G J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered photofrin. Jiang F; Lilge L; Grenier J; Li Y; Wilson MD; Chopp M Lasers Surg Med; 1998; 22(2):74-80. PubMed ID: 9484699 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly. Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic treatment of subcutaneous tumors in mice with photofrin II and Argon ion laser. You JS; Hau DM; Chen GT; Huang HF; Chen WC; Lin IH Chin Med J (Engl); 1996 Jan; 109(1):83-8. PubMed ID: 8758377 [TBL] [Abstract][Full Text] [Related]
13. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model. Li LB; Luo RC Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Toratani S; Tani R; Kanda T; Koizumi K; Yoshioka Y; Okamoto T Photodiagnosis Photodyn Ther; 2016 Jun; 14():104-10. PubMed ID: 26747657 [TBL] [Abstract][Full Text] [Related]
15. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models. Shi R; Li C; Jiang Z; Li W; Wang A; Wei J Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075 [TBL] [Abstract][Full Text] [Related]
16. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers. Xiao Z; Brown K; Tulip J; Moore RB J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188 [TBL] [Abstract][Full Text] [Related]
17. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. Nelson JS; McCullough JL; Berns MW J Natl Cancer Inst; 1988 Mar; 80(1):56-60. PubMed ID: 2963136 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of bladder cancer by Nd:YAG laser local irradiation and whole-bladder photodynamic therapy with hematoporphyrin derivative]. Li CL; Xu BZ; Shong XY Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):458-60. PubMed ID: 7720506 [TBL] [Abstract][Full Text] [Related]
20. Novel after-loading interstitial photodynamic therapy of canine transmissible sarcoma with photofrin II and excimer dye laser. Hashimoto Y; Hirano T; Yamaguchi N Jpn J Cancer Res; 1995 Feb; 86(2):239-44. PubMed ID: 7730150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]